Published in

American Association for Cancer Research, Cancer Research, 19_Supplement(74), p. 3994-3994, 2014

DOI: 10.1158/1538-7445.am2014-3994

Links

Tools

Export citation

Search in Google Scholar

Abstract 3994: Identifying molecular networks linked to colorectal liver metastasis progression during liver regeneration by RNA-seq

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract The only potential cure for colorectal liver metastasis (CRCLM) is hepatic resection; portal vein embolization (PVE) is used as an adjunct to stimulate liver regeneration and increase the number of resectable patients. PVE has been shown to enhance CRCLM progression in most patients. The objective of this study is to determine the molecular networks involved in CRCLM progression during liver regeneration, by transcriptome analysis (RNA-Seq). CRCLM RNA was procured prospectively from patients prior to and after PVE. 14 patients with PVE underwent tumor volumetric analysis (blinded from the transcriptome analysis) to determine stable vs. progressive disease. A subgroup of 9 patients had tumor progression (median 45.3% (95%CI 10.6-192.5%) increase in tumor volume) while the remaining patients exhibited stable disease and continuous chemotherapy response (median 26.0%(95%CI -53.1-1.2%) decrease in tumor volume) (p=0.0121), which was consistent with our published series of 123 patients. RNA extracted from tumor tissue (pre and post PVE) in a subset (n=6) of patients (median RNA Integrity number (RIN) scores 7.1 (6.2 - 9.0)) was used to prepare Illumina rRNA-depleted TruSeq stranded cDNA libraries for HiSeq 100bp paired-end sequencing. An average of 150 million reads and 91.8% genomic alignment was achieved per sample. The analysis revealed that several genes known to act as tumor suppressors in CRC (e.g. NR1H4 and HRG) are consistently down regulated post-PVE in the progressive group. Several canonical pathways (including acute phase response, LXR/RXR signaling) showed statistical enrichment for transcripts that were differentially expressed in patients with disease progression. This work aims to establish a comprehensive view of the transcriptional changes associated with CRCLM progression during liver regeneration, to identify the molecular mechanisms that drive metastatic progression in this unique context. Highlighting such mechanisms is a critical first step towards developing targeted therapeutic strategies that may mitigate the unwanted effects of liver regeneration on tumor growth. Citation Format: Eve Simoneau, Jarred Chicoine, Ayat Salman, Robert Sladek, Anthoula Lazaris, Ramila Amre, Peter Metrakos. Identifying molecular networks linked to colorectal liver metastasis progression during liver regeneration by RNA-seq. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3994. doi:10.1158/1538-7445.AM2014-3994